Resources Contact Us Home
Antisense oligonucleotides targeted to human CDC45

Image Number 4 for United States Patent #7393950.

Antisense oligonucleotides that inhibit expression of human replication-initiation protein as well as methods of preventing or treating hyperproliferative conditions using said oligonucleotides are disclosed. One aspect provides an antisense oligonucleotides that inhibits the expression of human replication-initiation protein and has a sequence complementary to at least a portion of a target sequence encoding a human replication-initiation gene. By administering a therapeutically effective amount of antisense oligonucleotides or by contacting the hyperproliferating cells with an effective amount of antisense oligonucleotides, expression of replication-initiation protein is inhibited. Methods of screening and testing active antisense oligonucleotides for their ability to inhibit gene expression are also disclosed.

  Recently Added Patents
System and method for operating an electric power converter
Antenna device and wireless communication apparatus
Tone enhancement bracket
Battery module
Pyridylphenyl compounds for inflammation and immune-related uses
Systems and methods for port mirroring with network-scoped connection-oriented sink
  Randomly Featured Patents
Navigation device
Power operated surfboard
Method and apparatus for the manufacture of shaped products of biaxially oriented polymeric material
Submucosa gel compositions
Method for forming a memory device by utilizing variations in resistance value
Induction heating coil for float zone melting of semiconductor rods
Finger ring
Device for feeding flat material
Wrist watch
Methods for multiplexed sample analysis